RxDoctor Payments Data

Rebecca Cao

Primary Care · Lee, MANPI 1558041327

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 86 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 10.6% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,350in general payments, 2019–2025

Across 86 payments — averaging $27.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$250
  • Lilly USA, LLC$228
  • AstraZeneca$205
  • Amgen$205
  • Lundbeck LLC$188
  • Sumitomo Pharma America, Inc.$155
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$2,350100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,350 in reported general payments places this provider in the 90th percentile of 181 primary care providers in Massachusetts.

See all primary care providers in Massachusetts

Medicare billing

Part B allowed, 2024
$36,460
Medicare patients
338
Services billed
566

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Albuterol Sulfate HfaAlbuterol Sulfate36$724
Ventolin HfaAlbuterol Sulfate13$719
Azithromycin38$227
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav40$223
Atorvastatin Calcium12$221
Doxycycline Hyclate27$196
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst25$176
Prednisone56$158
Celecoxib16$140
Bupropion XlBupropion Hcl11$109
Cephalexin12$104
Mupirocin16$100
Allopurinol14$82
Penicillin V Potassium19$82
Gabapentin25$81

Paid to pharmacies, not to this prescriber.

Other primary care in Lee

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →